MIRM
Mirum Pharmaceuticals Inc
$88.93
0.42 (0.48%) Today
1.39 (1.58%) After-hours
— up— down
Market Cap
$5.68B+20.2%
Revenue (TTM)
$594.72M+44.0%
Net Income (TTM)
$-887,100,452
$-887,100,452EPS (TTM)
-14.55
-14.55Shares Out
60.98M
60.98MOpen
$87.54
$87.54Previous Close
$87.96
$87.96Day Range
$86.51 – $90.31
$86.51 – $90.3152-Week Range
$63.23 – $130.00
$63.23 – $130.00Beta
0.76
0.76Volume
666.82K
666.82KAvg Volume
769.83K
769.83KAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout MIRM
Related
News
N/AN/AN/AN/A
Mirum's Brelovitug Meets Goal in Phase III AZURE-1 Study in HDV
Yahoo · 16h ago
Is Mirum Pharmaceuticals (MIRM) Undervalued On New Brelo Vitug Trial Data?
Yahoo · 20h ago
Baird Maintains Outperform on Mirum Pharmaceuticals, Raises Price Target to $130
Benzinga · 22h ago
MIRM Secures FDA Nod for an Ultra-Rare Bone Disorder Therapy
Yahoo · 1d ago
Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript
SeekingAlpha · 1d ago